SecBot SecBot
PRESS-RELEASE ·Filed Aug 12, 2026

TECH

Bio-Techne Corporation
NEUTRAL
Impact 4/10
Horizonmonths Processed3mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight • Neutral

The earnings release is largely procedural given the pending Merck KGaA acquisition. The stock's near-term path is tied to deal closing conditions and regulatory approvals, not quarterly operating performance. Monitor for shareholder vote dates and regulatory clearance milestones.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$72.23
T+0 close · Aug 12, 2026 · via day close
Latest settled
+0.60%
T+60 · $72.66
Vs SPY
+5.71%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 12 $72.23entry
  2. T+1 · 3mo ago −0.08%α −0.78% · $72.17
  3. T+5 · 3mo ago +0.35%α +0.79% · $72.48
  4. T+20 · 2mo ago −0.21%α +1.69% · $72.08
  5. T+60 · 12d ago +0.60%α +5.71% · $72.66
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Bio-Techne reported Q4 FY2026 adjusted EPS of $0.52, a 2.1% beat vs $0.52 consensus, on revenue of $321.2M (1% reported growth, 3% organic). Full-year revenue was flat at $1.2B. The results are largely procedural given the pending $73/share acquisition by Merck KGaA, with the company no longer holding earnings calls. The modest adjusted EPS decline and flat revenue are secondary to the deal's trajectory and premium.

Key Financial Metrics

EPS
$0.52
est $0.52 · 0.0%
Revenue
$321.2M
est $314.5M · +2.1% · +1.0% YoY
Rating
in line
Free Cash Flow
$263.2M
Gross Margin
65.8%

Key Facts

  • Q4 FY2026 revenue $321.2M, +1% reported / +3% organic vs prior year
  • Adjusted EPS $0.52 vs $0.53 a year ago, beating consensus of $0.52
  • GAAP EPS $0.35 vs $(0.11) a year ago, driven by prior-year impairment
  • Full-year FY2026 revenue flat at $1.2B; adjusted EPS $1.93 vs $1.92
  • Pending acquisition by Merck KGaA at $73/share (~$11.3B EV) dominates stock trajectory
  • Company no longer holding investor conference calls for quarterly results

Financial Impact

Q4 revenue $321.2M, adjusted EPS $0.52; full-year revenue $1.2B, adjusted EPS $1.93

revenueepsoperating margin

Risk Factors

  • Acquisition by Merck KGaA may face regulatory delays or fail to close
  • Flat full-year revenue and declining adjusted EPS signal limited organic growth momentum
  • No forward guidance provided; uncertainty about standalone performance if deal fails

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
41% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-prn-302849060

Track record

12 reports on TECH

Performance horizon

4 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +2.07% at T+60 after the Jun 25, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 12, 20265d ago 10-Q/A Neutral 1/10 Entry $72.80 Now $72.63 −0.23% settles Dec 14
  2. Nov 5, 202612d ago SC 13G/A Neutral 2/10 Entry $72.66 Now $72.63 −0.04% settles Dec 4
  3. Nov 3, 202613d ago 8-K Neutral 2/10 Entry $72.73 Now $72.63 −0.14% settles Dec 3
  4. Nov 3, 202613d ago Press Release Neutral 2/10 Entry $72.73 Now $72.63 −0.14% settles Dec 3
  5. Oct 29, 202619d ago Institutional Cluster Bearish 4/10 Entry $72.71 Now $72.63 +0.11% settles Nov 27
  6. Oct 28, 202620d ago 10-K/A Neutral 3/10 Entry $72.71 Now $72.63 −0.11% settles Nov 27
  7. Sep 23, 20267w ago 8-K Bullish 6/10 Entry $72.57 to $72.62 Now $72.63 +0.08% ▲ +0.07% +0.49% vs SPY
  8. Sep 23, 20267w ago Press Release Bullish 6/10 Entry $72.52 to $72.64 Now $72.63 +0.15% ▲ +0.17% −0.52% vs SPY
  9. Aug 12, 202613w ago 8-K Bullish 7/10 No price data
  10. Aug 12, 202613w ago Press Release Neutral 4/10 Viewing Entry $72.23 to $72.08 Now $72.63 +0.55% ▼ −0.21% +1.69% vs SPY
Showing 10 of 12

US Market Status

Market Closed · Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 12, 2026